Skip to main content
Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
15.72
+0.61 (4.04%)
At close: Mar 9, 2026, 4:00 PM EDT
15.68
-0.04 (-0.25%)
After-hours: Mar 9, 2026, 7:55 PM EDT

Summit Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
265
Market Cap
12.19B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022705.00K-1.10M-61.03%
Dec 31, 20211.81M949.00K110.35%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Jan 31, 2019 Pro Pro Pro
Jan 31, 2018 Pro Pro Pro
Jan 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Jazz Pharmaceuticals 4.27B
BioMarin Pharmaceutical 3.22B
Exelixis 2.32B
Madrigal Pharmaceuticals 958.40M
Ionis Pharmaceuticals 943.71M
Ascendis Pharma 845.52M
BridgeBio Pharma 502.08M
ImmunityBio 113.29M
Revenue Rankings

SMMT News

More News